Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sen. Grassley Seeks FDA Documents On Vioxx Labeling Changes

Nov 05 2004

• By Elizabeth Walker

Related Content

Merck Vioxx Communications With FDA Questioned By Senate Finance Cmte.

Oct 15 2004

FDA Memo Discussed Pulling Vioxx Based On HMO Study

Nov 03 2004

FDA Drug Safety Review Will Consider Pros And Cons Of Separate Safety Agency

Nov 05 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window